OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
January 14, 2011
Dishman is giving a step further in its strategy to manufacture high potency (HiPo) Active Pharmaceutical Ingredients (APIs).
January 07, 2011
Biopharmaceuticals commonly cannot be terminally sterilised, as such aseptic processing using sterilising grade filtration is essential.
December 02, 2010
World AIDS Day 2010 reminds us that prevention and hope can help fight the disease.
EMA Publishes New Transparency Policy, Releases Guideline for Biosimilar mAbs.
December 01, 2010
The growing uptake of single-use sterile packaging in pharmaceutical production processes mirrors the broader trend towards single-use across every sector of the pharmaceutical industry.
November 30, 2010
A European-wide awareness initiative hopes to tackle the issue of antibiotic over-prescription, but industry must also be encouraged to make further investments.
November 04, 2010
FDA Holds Biosimilars Public Hearing
November 02, 2010
Industrial and academic partnerships forge new territory in solid-state chemistry.
Today begins the two-day public hearing being held at FDA headquarters in Rockville, MD, to gain public in put on how to implement and regulate the follow-on biologics pathway that was cleared via President Obama's Biologics Price Competition and Innovation Act of 2009, which falls under the 2010 approved healthcare reform legislation.
The authors demonstrated that ODTs can be obtained by direct compression of a mixture of starch, fructose, and SMCC.